Christopher C Dvorak
Overview
Explore the profile of Christopher C Dvorak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
3758
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dvorak C, Temple W, Cisneros G, Chu J, Winestone L, Higham C, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39938805
Successful allogeneic hematopoietic cell transplantation (HCT) for genetic nonmalignant diseases (NMD) is dependent upon elimination of host hematopoietic stem cells (HSCs) and replacement with donor HSCs in stable numbers sufficient...
2.
Slatnick L, Hoogstra D, Fisher B, Wolf J, Orgel E, Nessle C, et al.
Pediatr Blood Cancer
. 2025 Jan;
72(3):e31532.
PMID: 39780366
Introduction: While clinical practice guidelines (CPGs) for pediatric oncology infection prophylaxis and management exist, few data describe actual management occurring at pediatric oncology centers. Methods: An electronic survey querying infection...
3.
Buso H, Adam E, Arkwright P, Bhattad S, Hamidieh A, Behfar M, et al.
J Clin Immunol
. 2024 Oct;
45(1):35.
PMID: 39470951
C1q deficiency is a rare inborn error of immunity characterized by increased susceptibility to infections and autoimmune manifestations mimicking SLE, with an associated morbidity and mortality. Because C1q is synthesized...
4.
Miranda M, Tsalatsanis A, Trotter J, Arnold D, Squire J, Kidd S, et al.
Clin Immunol
. 2024 Sep;
268:110364.
PMID: 39278553
No abstract available.
5.
Cheng G, Smith M, Phelan R, Brazauskas R, Strom J, Ahn K, et al.
Transplant Cell Ther
. 2024 Aug;
30(10):1017.e1-1017.e12.
PMID: 39089527
Diffuse alveolar hemorrhage (DAH) is a life-threatening pulmonary toxicity that can arise after hematopoietic cell transplantation (HCT). Risk factors and outcomes are not well understood owing to a sparsity of...
6.
Bognar T, Garcia-Rosa M, Lalmohamed A, Gungor T, Hauri-Hohl M, Prockop S, et al.
Blood Adv
. 2024 Jul;
8(19):5137-5145.
PMID: 39074263
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment strategy for patients with inborn errors of immunities (IEIs). The objective of this study was to assess the optimal busulfan...
7.
Dvorak C, Long-Boyle J, Holbrook-Brown L, Abdel-Azim H, Bertaina A, Vatsayan A, et al.
Blood Adv
. 2024 Jul;
8(23):6003-6014.
PMID: 39042892
We hypothesized that the inferior disease-free survival (DFS) seen in older patients who underwent αβ-T-cell/CD19-depleted (AB-TCD) haploidentical hematopoietic cell transplantation (HCT) for hematologic malignancies is caused by excessive exposure to...
8.
Higham C, Shimano K, Kharbanda S, Chu J, Cisneros G, Winestone L, et al.
Transplant Cell Ther
. 2024 Jun;
30(9):931.e1-931.e10.
PMID: 38944154
Transplant associated thrombotic microangiopathy (TA-TMA) is a complication of hematopoietic cell transplant (HCT) associated with endothelial injury resulting in severe end organ damage, acute and long-term morbidity, and mortality. Myeloablative...
9.
Smith M, Cheng G, Phelan R, Brazauskas R, Strom J, Ahn K, et al.
Front Oncol
. 2024 Jun;
14:1415984.
PMID: 38868534
Objective: To determine the incidence, risk factors, and outcomes of pulmonary hypertension (PH) in the pediatric intensive care unit (PICU) after pediatric hematopoietic stem cell transplant (HCT). Methods: This was...
10.
Zinter M, Dvorak C, Mayday M, Reyes G, Simon M, Pearce E, et al.
Nat Med
. 2024 May;
30(7):1982-1993.
PMID: 38783139
Hematopoietic cell transplantation (HCT) uses cytotoxic chemotherapy and/or radiation followed by intravenous infusion of stem cells to cure malignancies, bone marrow failure and inborn errors of immunity, hemoglobin and metabolism....